The use of pamidronate in PTHrP associated hypercalcaemia in infancy.
Buckmaster
A
A
Ray Williams Institute of Paediatric Endocrinology, Diabetes and Metabolism, New Children's Hospital, Parramatta, NSW, Australia.
Rodda
C
C
Cowell
C T
CT
Ogle
G
G
Dorney
S
S
D004164:Diphosphonates / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology*; D007223:Infant; D019189:Iron Metabolism Disorders / Q000150:complications; D007680:Kidney Neoplasms / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D008297:Male; D000077268:Pamidronate; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000378:metabolism*; D018335:Rhabdoid Tumor / Q000150:complications / Q000175:diagnosis / Q000601:surgery
D004164:Diphosphonates; C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D000077268:Pamidronate